Parenteral controlled therapy, using a porous matrix with parenteral agent
First Claim
Patent Images
1. A parenteral delivery set for administering a beneficial agent formulation to a warm-blooded animal, the delivery set comprising:
- (a) a primary tube for the flow of a parenterally acceptable fluid therethrough;
(b) a secondary tube for the flow of a parenterally acceptable fluid therethrough;
(c) a formulation chamber in communication with the secondary tube, the formulation chamber comprising;
(1) a wall that surrounds an internal space;
(2) an inlet for letting fluid enter the formulation chamber;
(3) a beneficial agent delivery device in the formulation chamber, the delivery device comprising a matrix formed of a microporous material, and a beneficial agent distributed in the microporous material;
(4) an outlet for letting an agent formulation exit the formulation chamber; and
,(d) a common tube in communication with the primary tube for receiving fluid from the primary tube, and in communication with the secondary tube for receiving agent formulation from the secondary tube.
0 Assignments
0 Petitions
Accused Products
Abstract
A parenteral delivery set is disclosed for administering a beneficial agent to a recipient. The set comprises (a) a primary container of a medical fluid; (b) a primary tubing in fluid communication with the primary container; (c) a secondary container of a medical fluid; (d) a secondary tubing in fluid communication with the secondary container; (e) a formulation chamber connected to the secondary tubing and housing an agent dispensing device or the beneficial agent; and (f) a common tubing in communication with the primary tubing and the secondary tubing for communicating the set to the recipient.
130 Citations
3 Claims
-
1. A parenteral delivery set for administering a beneficial agent formulation to a warm-blooded animal, the delivery set comprising:
-
(a) a primary tube for the flow of a parenterally acceptable fluid therethrough; (b) a secondary tube for the flow of a parenterally acceptable fluid therethrough; (c) a formulation chamber in communication with the secondary tube, the formulation chamber comprising; (1) a wall that surrounds an internal space; (2) an inlet for letting fluid enter the formulation chamber; (3) a beneficial agent delivery device in the formulation chamber, the delivery device comprising a matrix formed of a microporous material, and a beneficial agent distributed in the microporous material; (4) an outlet for letting an agent formulation exit the formulation chamber; and
,(d) a common tube in communication with the primary tube for receiving fluid from the primary tube, and in communication with the secondary tube for receiving agent formulation from the secondary tube. - View Dependent Claims (2, 3)
-
Specification